Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04770896
Title A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab (IMbrave251)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

hepatocellular carcinoma

Therapies

Atezolizumab + Lenvatinib

Lenvatinib + Sorafenib

Atezolizumab + Sorafenib

Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.